Compare AU
Compare HACK vs. CURE
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Cybersecurity ETF (HACK) and the S&P US Biotech (CURE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
HACK | CURE | |
|---|---|---|
Popularity | Medium | Low |
Pearlers invested | 1,386 | 80 |
Median incremental investment | $750.00 | $620.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,081.52 | $1,269.62 |
Average age group | 26 - 35 | > 35 |
Key Summary
HACK | CURE | |
|---|---|---|
Strategy | HACK seeks to track the performance of the NASDAQ CTA Cybersecurity Index prior to expenses and fees. | CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index. |
Top 3 holdings | BROADCOM INC (11.00 %) CROWDSTRIKE HOLDINGS INC (8.16 %) CISCO SYSTEMS INC (7.85 %) | Neurocrine Biosciences Inc (2.71 %) Alnylam Pharmaceuticals Inc (2.47 %) Biomarin Pharmaceutical Inc (2.47 %) |
Top 3 industries | Information Technology (74.40 %) Other (17.35 %) Industrials (8.25 %) | Health Care (100.00 %) Other (10.24 %) |
Top 3 countries | United States (79.37 %) India (7.63 %) Israel (3.99 %) | United States (97.17 %) Switzerland (1.51 %) United Kingdom of Great Britain and Northern Ireland (1.16 %) |
Management fee | 0.67 % | 0.45 % |
Key Summary
HACK | CURE | |
|---|---|---|
Issuer | BetaShares | Global X |
Tracking index | Nasdaq CTA Cybersecurity Index - AUD | S&P Biotechnology Select Industry |
Asset class | ETF | ETF |
Management fee | 0.67 % | 0.45 % |
Price | $14.22 | $48.71 |
Size | $1.155 billion | $36.961 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 4.95 % | 4.24 % |
Market | ASX | ASX |
First listed date | 01/09/2016 | 12/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
HACK | CURE | |
|---|---|---|
Popularity | Medium | Low |
Pearlers invested | 1,386 | 80 |
Median incremental investment | $750.00 | $620.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,081.52 | $1,269.62 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
HACK | CURE | |
|---|---|---|
Pros |
|
|
Cons |
|
|
HACK | CURE |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |